Literature DB >> 20122554

Relationship between sleep apnea syndrome and sleep blood pressure in patients without hypertension.

Hiromitsu Sekizuka1, Keisuke Kida, Yoshihiro J Akashi, Kihei Yoneyama, Naohiko Osada, Kazuto Omiya, Fumihiko Miyake.   

Abstract

BACKGROUND AND
PURPOSE: Ambulatory blood pressure monitoring (ABPM) provides an accurate assessment of blood pressure (BP) and shows non-dipper BP pattern in many sleep apnea syndrome (SAS) patients with hypertension (HTN); however, little information is available on the relationship between the severity of SAS and circadian BP changes in SAS patients without HTN. This study investigated whether SAS patients without HTN would have different BP courses in the severity of SAS. METHODS AND
SUBJECTS: Seventy-four consecutive outpatients without HTN [systolic BP (BPs) at clinic <140mmHg and/or diastolic BP (BPd) at clinic <90mmHg], who received no antihypertensives, underwent overnight polysomnography (PSG) and ABPM. The apnea-hypopnea index (AHI) was calculated from the PSG results; patients were stratified into the following 4 groups based on their AHI: non-SAS, mild-, moderate-, or severe-SAS.
RESULTS: The diurnal BPs and BPd showed no differences in the severity of SAS; however, the sleep BPs, lowest BPs, and pre-awake BPs were significantly higher in the severe-SAS group than the non-SAS group (p=0.02, p=0.04, and p=0.006, respectively). The sleep BPd and pre-awake BPd were significantly higher in the severe-SAS than the non-SAS (p=0.01 and p=0.0003, respectively) and mild-SAS (p=0.01 and p=0.008, respectively) groups.
CONCLUSIONS: The results of this study suggested that SAS affected nocturnal BP elevation even in SAS patients without HTN. The diurnal BP showed no difference in the severity of SAS; however, the severe-SAS group revealed significant nocturnal BP elevation. 2009 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20122554     DOI: 10.1016/j.jjcc.2009.10.002

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  7 in total

1.  Morning Diastolic Blood Pressure May Be Independently Associated With Severity of Obstructive Sleep Apnea in Non-Hypertensive Patients: A Cross-Sectional Study.

Authors:  Łukasz Mokros; Wojciech Kuczyński; Łukasz Franczak; Piotr Białasiewicz
Journal:  J Clin Sleep Med       Date:  2017-07-15       Impact factor: 4.062

2.  Impact of depression on masked hypertension and variability in home blood pressure in treated hypertensive patients.

Authors:  Hiroyuki Kayano; Shinji Koba; Taiju Matsui; Hiroto Fukuoka; Kyouichi Kaneko; Makoto Shoji; Tsutomu Toshida; Norikazu Watanabe; Eiichi Geshi; Youichi Kobayashi
Journal:  Hypertens Res       Date:  2015-07-02       Impact factor: 3.872

3.  Impact of obstructive sleep apnea and hypertension on left ventricular hypertrophy in Japanese patients.

Authors:  Hiromitsu Sekizuka; Naohiko Osada; Yoshihiro J Akashi
Journal:  Hypertens Res       Date:  2016-12-01       Impact factor: 3.872

4.  A daytime normotensive patient with nocturnal hypoxia-induced hypertension and severe obstructive sleep apnea.

Authors:  Hiromitsu Sekizuka; Satoshi Hoshide; Naohiko Osada; Yoshihiro J Akashi; Kazuomi Kario
Journal:  J Cardiol Cases       Date:  2017-06-30

5.  Twenty-four hour Blood Pressure in Obese Patients with Moderate-to-Severe Obstructive Sleep Apnea.

Authors:  Claudia M Correa; Ronaldo A Gismondi; Ana Rosa Cunha; Mario F Neves; Wille Oigman
Journal:  Arq Bras Cardiol       Date:  2017-09-04       Impact factor: 2.000

6.  The Factors Affecting the Non-dipper Pattern in Japanese Patients with Severe Obstructive Sleep Apnea.

Authors:  Hiromitsu Sekizuka; Naohiko Osada; Yoshihiro J Akashi
Journal:  Intern Med       Date:  2018-01-11       Impact factor: 1.271

7.  The Effects of Eplerenone on the Circadian Blood Pressure Pattern and Left Ventricular Hypertrophy in Patients with Obstructive Sleep Apnea and Resistant Hypertension-A Randomized, Controlled Trial.

Authors:  Beata Krasińska; Szczepan Cofta; Ludwina Szczepaniak-Chicheł; Piotr Rzymski; Tomasz Trafas; Lech Paluszkiewicz; Andrzej Tykarski; Zbigniew Krasiński
Journal:  J Clin Med       Date:  2019-10-13       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.